XML 39 R24.htm IDEA: XBRL DOCUMENT v3.25.3
Earnings Per Share ("EPS")
9 Months Ended
Sep. 30, 2025
Earnings Per Share [Abstract]  
Earnings Per Share ("EPS") Earnings Per Share (“EPS”)
Three Months EndedNine Months Ended
September 30,September 30,
(in millions)2025202420252024
Net income available for common stockholders(a)
$51.3 $34.6 $50.2 $184.2 
Less: Distributions to holders of Series A Preferred Stock
2.2 2.2 6.6 6.6 
Net income available for common stockholders(b)
$49.1 $32.4 $43.6 $177.6 
Weighted average shares for basic EPS167.2 162.0 166.9 161.8 
Dilutive potential shares from grants of RSUs and PRSUs1.3 1.2 1.2 0.8 
Dilutive potential shares issuable upon conversion of Series A Preferred Stock7.8 — — 7.8 
Weighted average shares for diluted EPS(c)(d)
176.3 163.2 168.1 170.4 
(a)For the three months ended September 30, 2025, and the nine months ended September 30, 2024, Net income available for common stockholders for the calculation of diluted EPS.
(b)For the nine months ended September 30, 2025, and the three months ended September 30, 2024, Net income available for common stockholders for the calculation of both basic and diluted EPS. For the three months ended September 30, 2025, and the nine months ended September 30, 2024, Net income available for common stockholders for the calculation of basic EPS.
(c)The potential impact of 0.1 million granted RSUs and PRSUs in the three months ended September 30, 2025, 0.1 million granted RSUs and PRSUs in the nine months ended September 30, 2025, and 1.0 million granted RSUs and PRSUs in the nine months ended September 30, 2024, were antidilutive.
(d)The potential impact of 7.8 million shares of our common stock issuable upon conversion of the Series A Preferred Stock in the three months ended September 30, 2024 and 7.8 million shares of our common stock issuable upon conversion of the Series A Preferred Stock in the nine months ended September 30, 2025, were antidilutive.